362 related articles for article (PubMed ID: 16240899)
1. Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients.
Tanaka M; Ohashi T; Kobayashi M; Eto Y; Miyamura N; Nishida K; Araki E; Itoh K; Matsushita K; Hara M; Kuwahara K; Nakano T; Yasumoto N; Nonoguchi H; Tomita K
Clin Nephrol; 2005 Oct; 64(4):281-7. PubMed ID: 16240899
[TBL] [Abstract][Full Text] [Related]
2. An atypical variant of Fabry's disease in men with left ventricular hypertrophy.
Nakao S; Takenaka T; Maeda M; Kodama C; Tanaka A; Tahara M; Yoshida A; Kuriyama M; Hayashibe H; Sakuraba H
N Engl J Med; 1995 Aug; 333(5):288-93. PubMed ID: 7596372
[TBL] [Abstract][Full Text] [Related]
3. Screening Fabry's disease in chronic kidney disease patients not on dialysis: a multicenter study.
Yeniçerioğlu Y; Akdam H; Dursun B; Alp A; Sağlam Eyiler F; Akın D; Gün Y; Hüddam B; Batmazoğlu M; Gibyeli Genek D; Pirinççi S; Ersoy İR; Üzüm A; Soypaçacı Z; Tanrısev M; Çolak H; Demiral Sezer S; Bozkurt G; Akyıldız UO; Akyüz Ünsal Aİ; Ünübol M; Uslu M; Eryılmaz U; Günel C; Meteoğlu İ; Yavaşoğlu İ; Ünsal A; Akar H; Okyay P
Ren Fail; 2017 Nov; 39(1):104-111. PubMed ID: 27832731
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic, biochemical, and clinical studies in three families with cardiac Fabry's disease.
Yoshitama T; Nakao S; Takenaka T; Teraguchi H; Sasaki T; Kodama C; Tanaka A; Kisanuki A; Tei C
Am J Cardiol; 2001 Jan; 87(1):71-5. PubMed ID: 11137837
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and genetic analysis of a Chinese kindred with Fabry's disease.
Tse KC; Chan KW; Tin VP; Yip PS; Tang S; Li FK; Ho YW; Lai KN; Chan TM
Nephrol Dial Transplant; 2003 Jan; 18(1):182-6. PubMed ID: 12480979
[TBL] [Abstract][Full Text] [Related]
6. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype.
Nakao S; Kodama C; Takenaka T; Tanaka A; Yasumoto Y; Yoshida A; Kanzaki T; Enriquez AL; Eng CM; Tanaka H; Tei C; Desnick RJ
Kidney Int; 2003 Sep; 64(3):801-7. PubMed ID: 12911529
[TBL] [Abstract][Full Text] [Related]
7. Megadolichobasilar anomaly with thrombosis in a family with Fabry's disease and a novel mutation in the alpha-galactosidase A gene.
Garzuly F; Maródi L; Erdös M; Grubits J; Varga Z; Gelpi E; Rohonyi B; Mázló M; Molnár A; Budka H
Brain; 2005 Sep; 128(Pt 9):2078-83. PubMed ID: 15947062
[TBL] [Abstract][Full Text] [Related]
8. [Ocular findings in Fabry's disease].
Kuzman T; Juri J; Mrsić M; Jeren-Strujić B; Mandić Z; Sikić J
Acta Med Croatica; 2006; 60(2):163-6. PubMed ID: 16848212
[TBL] [Abstract][Full Text] [Related]
9. Cardiopulmonary involvement in Fabry's disease.
Koskenvuo JW; Kantola IM; Nuutila P; Knuuti J; Parkkola R; Mononen I; Hurme S; Kalliokoski R; Viikari JS; Wendelin-Saarenhovi M; Kiviniemi TO; Hartiala JJ
Acta Cardiol; 2010 Apr; 65(2):185-92. PubMed ID: 20458826
[TBL] [Abstract][Full Text] [Related]
10. [Myocardial disease in inherited disease].
Nakao S
Nihon Rinsho; 2000 Jan; 58(1):200-3. PubMed ID: 10885314
[TBL] [Abstract][Full Text] [Related]
11. Enzyme replacement therapy in patients with Fabry's disease.
Tsuboi K
J Int Med Res; 2007; 35(4):574-81. PubMed ID: 17697536
[TBL] [Abstract][Full Text] [Related]
12. Enzyme replacement therapy in Fabry's disease: recent advances and clinical applications.
Mignani R; Cagnoli L
J Nephrol; 2004; 17(3):354-63. PubMed ID: 15365954
[TBL] [Abstract][Full Text] [Related]
13. Endothelial nitric oxide synthase gene polymorphisms in Fabry's disease.
Heltianu C; Costache G; Azibi K; Poenaru L; Simionescu M
Clin Genet; 2002 Jun; 61(6):423-9. PubMed ID: 12121349
[TBL] [Abstract][Full Text] [Related]
14. Screening for Fabry disease in patients undergoing dialysis for chronic renal failure in Turkey: identification of new case with novel mutation.
Okur I; Ezgu F; Biberoglu G; Tumer L; Erten Y; Isitman M; Eminoglu FT; Hasanoglu A
Gene; 2013 Sep; 527(1):42-7. PubMed ID: 23756194
[TBL] [Abstract][Full Text] [Related]
15. Fabry disease female proband with clinical manifestations similar to hypertrophic cardiomyopathy.
Teragaki M; Tanaka A; Akioka K; Lan HT; Nishi Y; Yamano T; Yoshikawa J
Jpn Heart J; 2004 Jul; 45(4):685-9. PubMed ID: 15353880
[TBL] [Abstract][Full Text] [Related]
16. The frequency of Fabry disease with the E66Q variant in the α-galactosidase A gene in Japanese dialysis patients: a case report and a literature review.
Kikumoto Y; Sugiyama H; Morinaga H; Inoue T; Takiue K; Kitagawa M; Saito D; Takatori Y; Kinomura M; Kitamura S; Akagi S; Sada K; Nakao K; Maeshima Y; Kitayama H; Makino H
Clin Nephrol; 2012 Sep; 78(3):224-9. PubMed ID: 22874111
[TBL] [Abstract][Full Text] [Related]
17. Genetics and Gene Therapy of Anderson-Fabry Disease.
Simonetta I; Tuttolomondo A; Di Chiara T; Miceli S; Vogiatzis D; Corpora F; Pinto A
Curr Gene Ther; 2018; 18(2):96-106. PubMed ID: 29618309
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Fabry's disease within hemodialysis patients in Spain.
Herrera J; Miranda CS
Clin Nephrol; 2014 Feb; 81(2):112-20. PubMed ID: 24365053
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1.
Connock M; Juarez-Garcia A; Frew E; Mans A; Dretzke J; Fry-Smith A; Moore D
Health Technol Assess; 2006 Jun; 10(20):iii-iv, ix-113. PubMed ID: 16729919
[TBL] [Abstract][Full Text] [Related]
20. Fabry's disease: clinical, pathologic and biochemical manifestations in two Chinese males.
Sheu SS; Chan LP; Liao SC; Hsiao KJ; Shu KH; Lu YS; Cheng CH; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Nov; 54(5):368-72. PubMed ID: 7834562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
